MYLAN INSTITUTIONAL FDA Approval ANDA 040541

ANDA 040541

MYLAN INSTITUTIONAL

FDA Drug Application

Application #040541

Documents

Letter2004-11-16

Application Sponsors

ANDA 040541MYLAN INSTITUTIONAL

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INJECTION20MG/2ML (10MG/ML)0SOTRADECOLSODIUM TETRADECYL SULFATE
002INJECTABLE;INJECTION60MG/2ML (30MG/ML)0SOTRADECOLSODIUM TETRADECYL SULFATE

FDA Submissions

ORIG1AP2004-11-12
LABELING; LabelingSUPPL4AP2008-05-30
LABELING; LabelingSUPPL14AP2018-03-01STANDARD
LABELING; LabelingSUPPL15AP2019-05-22STANDARD

Submissions Property Types

ORIG1Null1
SUPPL14Null15
SUPPL15Null15

TE Codes

002PrescriptionAP

CDER Filings

MYLAN INSTITUTIONAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40541
            [companyName] => MYLAN INSTITUTIONAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"SOTRADECOL","activeIngredients":"SODIUM TETRADECYL SULFATE","strength":"20MG\/2ML (10MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"},{"drugName":"SOTRADECOL","activeIngredients":"SODIUM TETRADECYL SULFATE","strength":"60MG\/2ML (30MG\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SOTRADECOL","submission":"SODIUM TETRADECYL SULFATE","actionType":"20MG\/2ML (10MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"SOTRADECOL","submission":"SODIUM TETRADECYL SULFATE","actionType":"60MG\/2ML (30MG\/ML)","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.